References
-
1) Therapeutic Effect of Biejiaxiaozheng Pills on Carbon Tetrachloride-Induced Hepatic Fibrosis in Rats through the NF-κB/Nrf2 Pathway.
Product: NF-kB p65 Antibody (#AF5006)Year: 2021Journal: GASTROENT RES PRACTImpactFactor: 2DOI: 10.1155/2021/3954244PMID: 34868305 -
2) Spinal Nrf2 translocation may inhibit neuronal NF‐κB activation and alleviate allodynia in a rat model of bone cancer pain.
Product: NF-kB p65 Antibody (#AF5006)Year: 2021Journal: J NEUROCHEMImpactFactor: 4.2DOI: 10.1111/jnc.15468PMID: 34254317 -
3) The Extract of Sonneratia apetala Leaves and Branches Ameliorates Hyperuricemia in Mice by Regulating Renal Uric Acid Transporters and Suppressing the Activation of the JAK/STAT Signaling Pathway.
Product: NF-kB p65 Antibody (#AF5006)Year: 2021Journal: FRONT PHARMACOLImpactFactor: 5.6DOI: 10.3389/fphar.2021.698219PMID: 34483901 -
4) Perillaldehyde Alleviates Spinal Cord Ischemia-Reperfusion Injury Via Activating the Nrf2 Pathway.
Product: NF-kB p65 Antibody (#AF5006)Year: 2021Journal: J SURG RESImpactFactor: 1.8DOI: 10.1016/j.jss.2021.06.055PMID: 34399353 -
5) Icariin Inhibits Intestinal Inflammation of DSS-Induced Colitis Mice Through Modulating Intestinal Flora Abundance and Modulating p-p65/p65 Molecule.
Product: NF-kB p65 Antibody (#AF5006)Year: 2021Journal: TURK J GASTROENTEROLImpactFactor: 1.4DOI: 10.5152/tjg.2021.20282PMID: 34231485 -
6) The STING antagonist H‐151 ameliorates psoriasis via suppression of STING/NF‐κB‐mediated inflammation.
Product: NF-kB p65 Antibody (#AF5006)Year: 2021Journal: BRIT J PHARMACOLImpactFactor: 6.8DOI: 10.1111/bph.15673PMID: 34460100 -
7) Melatonin protects cochlear hair cells from nicotine‐induced injury through inhibiting apoptosis, inflammation, oxidative stress and endoplasmic reticulum stress.
Product: NF-kB p65 Antibody (#AF5006)Year: 2021Journal: BASIC CLIN PHARMACOLImpactFactor: 2.7DOI: 10.1111/bcpt.13638PMID: 34254721 -
8) Protective effects of miR‑155‑5p silencing on IFN‑γ‑induced apoptosis and inflammation in salivary gland epithelial cells.
Product: NF-kB p65 Antibody (#AF5006)Year: 2021Journal: EXP THER MEDImpactFactor: 2.4DOI: 10.3892/etm.2021.10314PMID: 34194560 -
9) Patchouli alcohol ameliorates acute liver injury via inhibiting oxidative stress and gut-origin LPS leakage in rats.
Product: NF-kB p65 Antibody (#AF5006)Year: 2021Journal: INT IMMUNOPHARMACOLImpactFactor: 4.8DOI: 10.1016/j.intimp.2021.107897PMID: 34182243 -
10) miR-19a-3p downregulates tissue factor and functions as a potential therapeutic target for sepsis-induced disseminated intravascular coagulation.
Product: NF-kB p65 Antibody (#AF5006)Year: 2021Journal: BIOCHEM PHARMACOLImpactFactor: 5.3DOI: 10.1016/j.bcp.2021.114671PMID: 34246626 -
11) Systems pharmacology and transcriptomics reveal the mechanisms of Sanhuang decoction enema in the treatment of ulcerative colitis with additional Candida albicans infection.
Product: NF-kB p65 Antibody (#AF5006)Year: 2021Journal: CHIN MED-UKImpactFactor: 5.3DOI: 10.1186/s13020-021-00487-2PMID: 34376226 -
12) Phenolic Compounds from Mori Cortex Ameliorate Sodium Oleate-Induced Epithelial–Mesenchymal Transition and Fibrosis in NRK-52e Cells through CD36.
Product: NF-kB p65 Antibody (#AF5006)Year: 2021Journal: MOLECULESImpactFactor: 4.6DOI: 10.3390/molecules26206133PMID: 34684716 -
13) Guizhi-Shaoyao-Zhimu decoction attenuates bone erosion in rats that have collagen-induced arthritis via modulating NF‐κB signalling to suppress osteoclastogenesis.
Product: NF-kB p65 Antibody (#AF5006)Year: 2021Journal: PHARM BIOLImpactFactor: 3.9DOI: 10.1080/13880209.2021.1876100PMID: 33626293 -
14) Gut microbiota-mediated transformation of coptisine into a novel metabolite 8-oxocoptisine: Insight into its superior anti-colitis effect.
Product: NF-kB p65 Antibody (#AF5006)Year: 2021Journal: FRONT PHARMACOLImpactFactor: 5.6DOI: 10.3389/fphar.2021.639020PMID: 33859564 -
15) Helicobacter pylori Regulates the Apoptosis of Human Megakaryocyte Cells via NF-κB/IL-17 Signaling.
Product: NF-kB p65 Antibody (#AF5006)Year: 2021Journal: ONCOTARGETS THERImpactFactor: 2.7DOI: 10.2147/OTT.S268056PMID: 33776453